Mankind Pharma's ANDA220513 for Thiamine Hydrochloride Receives AP Status
Mankind Pharma's application ANDA220513 for Thiamine Hydrochloride has received an Approval Pending (AP) status.
Therapeutic Area
Therapeutic area intelligence for Vitamin B1 with 1 indexed intelligence signal across regulatory, clinical, competitive, and market developments.
No catalysts indexed for this entity yet.
No related entities indexed yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.